Preparing for April 3 hearing to argue case against DEA's suspension of its license to ship controlled substances from its Lakeland, Florida distribution center. Comments taken from presentation at Barclays Global Healthcare conference.
Concerns over the future of the U.S. Federal Reserve's monetary stimulus and weak Chinese factory data sent shares …